• Orthopaedic spine surgeon, entrepreneur, and cofounder/board member of multiple successful startup ventures
  • Founding Partner at K2M (purchased by Stryker) and Electrocore (recently went public, NASDAQ: ECOR).

Principal and CEO

These surfaces are slippery (nearly superhydrophobic)  and reduce resistance between material surfaces or the environment, essentially allowing for self-cleaning surfaces.

​Our target applications are to create surfaces that are:

Technology and Science Driven

Surface functionalization refers to chemically modifying surfaces to create a property of that surface not initial present.  For example, anodization is a functionalization process that makes the surface of a metal resistant to corrosion while maintaining the integrity and behavior of the underlying bulk metal substrate.

Bioactive

Functionalized Surfaces

Marc H. Burel

Lubricious

Antimicrobial

Doing something that is good and something yatta yatta about covalent surface treatments

Principal and Chief Scientific Officer

Principal and Founder

​MST is a science and technology company dedicated to developing and licensing/selling its technologies to companies who manufacturer/distribute end products. From a development point of view, we invent, refine and provide a final surface modification strategy for specific products to meet our development partner company’s needs. This may include all scientific and technical support to achieve regulatory approval and scalable manufacturing.  One example would be treating a joint replacement implant to kill bacteria that comes in contact with it.  MST would provide the transfer technology and support data needed for FDA approval, and assist in scalable manufacturing.  From a business standpoint, MST does not invest in costly inventory and distribution infrastructure greatly diminishing anticipated costs.

Leadership Team

"Antimicrobial" generally refers to the killing of bacteria, fungi, and molds. MST creates surfaces that very quickly and potently kill bacteria and fungi, keeping materials microbe free.

Biologically-active surface modifications can advance cellular adhesion and growth directly on the material surface, allowing for improved, more economic, and environmentally-friendly biologic activity.

  • Established R&D agreements with five companies that brought Orthobond to a cash flow-positive position
  • Veteran of the medical industry with over 25 years of experience in sales, marketing, and management

Press and Events

  • Former Vice President of Research and Development at Orthobond
  • Extensive experience in the covalent attachment of active end groups to various substrates and achieving goals for regulatory approval

Gordon D. Donald, M.D.

Randy Clevenger, Ph.D.